Terrapeutics

Terrapeutics developed a drug discovery platform that is based on a groundbreaking technology enabling us to go back to the best source of drugs – nature. Nature used to be the most prolific source for therapeutic molecules, but current discovery methods can only utilize a 0.1% fraction of it. We paved the way to look at the staggering 99.9% that is a huge blind spot to most of the pharma industry. Our technology efficiently screens for drugs against the most challenging targets out there. Our current focus is RAS inhibitors and infectious diseases, with plans to expand to additional drug targets that are considered "undruggable" to date